Cannabis and mental health risks are often overstated in public debate. Research shows heavy use and high THC exposure can increase psychosis risk in vulnerable individuals, but widespread claims of a mental health crisis lack strong evidence. This piece examines the data, separates correlation from causation, and breaks down what cannabis users need to know.
CANNABIS LIES Vol. 6: The Driving Apocalypse Lie
Legal cannabis is often blamed for rising traffic deaths, but federal data tells a more complicated story. NHTSA findings, toxicology limitations, and conflicting crash studies reveal that THC presence is not a reliable measure of impairment. This investigation breaks down how flawed testing and policy shortcuts have shaped the narrative around so-called stoned driving.
The Study That Pretends Cannabis Does Nothing
A new cannabis study claims marijuana does nothing for anxiety, depression, or PTSD. The reality is far more complicated. Decades of federal restrictions, limited research access, and synthetic substitutes have shaped the science. This breakdown exposes how incomplete data and selective interpretation continue to drive misleading headlines about cannabis and mental health.
Cannabis Study Sparks Fear Among the Uninformed
A McMaster-led analysis of two Canadian mental health surveys is getting recycled as a weed panic story, even though the design can only show association. This piece breaks down what the data can actually support, what it cannot prove, and how headlines turn survey correlations into causal claims that fuel stigma, bad policy, and lazy coverage.
Alcohol Math Isn’t Cannabis Science
A new study claims cannabis can be measured like alcohol using weekly limits and risk tiers. This feature dismantles that framework, exposing how alcohol math distorts cannabis science, ignores human biology, and fuels modern prohibition under the guise of public health. Numbers may comfort regulators, but they do not reflect reality.
THE PRODUCT THEY NEVER TEST
Hospitals increasingly diagnose Cannabinoid Hyperemesis Syndrome without testing the cannabis products involved. This investigation examines how cartridges, edibles, and other cannabis materials are excluded from medical evaluation, despite known contamination risks, leaving patients with diagnoses based on symptoms and self reported use rather than verified evidence.